Related Experiment Video
Updated: May 27, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The Maxwell Finland Lecture 2025: Antimicrobial Resistance At The Bedside: Translating Science Into Patient Outcomes
Cesar A Arias1,2,3
1Charles W. Duncan Jr. Department of Medicine, Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.
Abstract:
Antimicrobial resistance (AMR) is one of the most pressing public health threats of the 21st century. The development of resistance to antimicrobial agents is multifactorial. However, a major driver of AMR is the remarkable capacity of microorganisms to rapidly evolve, continually challenging the practice of infectious diseases and undermining the effectiveness of miracle drugs we call antibiotics. Dr. Maxwell Finland was a pioneer in this field, uniquely positioned to witness-and help shape-the transition from an era without antimicrobials to one transformed by life-saving therapies that revolutionized medicine. As AMR continues to rise and antibiotics cease to be effective, Dr. Finland's legacy is more relevant than ever.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microorganisms in Medicine and Therapeutics